NCT01615003

The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease

The Analysis of Blood Stasis Syndromeand of Coronary Heart Disease Related MicroRNA Genomics and Target Gene Regulatory Networks

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 70 (estimated)
• Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
• Sex: All
• Age: 30 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

In this study, typical cases of blood stasis syndrome of coronary heart disease are selected, by using microRNA chip, cDNA microarray and other bioinformatics technologies to filter and verify related miRNA and its target gene of Coronary Heart disease. Meanwhile, intervene by Xuesaitong soft capsules to investigate related miRNA and its target gene of Coronary Heart disease.

Conditions

• Coronary Heart Disease
• Unstable Angina
• Blood Stasis Syndrome

Interventions

Type	Name	Description
DRUG	Xuesaitong soft capsule	Xuesaitong soft capsule, soft capsule, Ingredients:PNS, Specification:0.33 per bag, once take two pills and twice a day during a month.
DRUG	Xuesaitong soft capsule Placebo	Xuesaitong soft capsule Placebo, soft capsule, once take two pills and twice a day during a month.

Timeline

• Start date: 2012-05-01
• Primary completion: 2014-07-01
• Completion: 2014-12-01
• First posted: 2012-06-08
• Last updated: 2014-01-14

Locations

1 site across 1 country: China